---
title: WGX50 mitigates doxorubicin-induced cardiotoxicity through inhibition of mitochondrial
  ROS and ferroptosis
date: '2023-11-18'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/37978379/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20231118170631&v=2.17.9.post6+86293ac
source: heidelberg[Affiliation]
description: 'CONCLUSION: Taken together, WGX50 protects DOX-induced cardiotoxicity
  via mitochondrial ROS and the ferroptosis pathway, which provides novel insights
  for WGX50 as a promising drug candidate for ...'
disable_comments: true
---
CONCLUSION: Taken together, WGX50 protects DOX-induced cardiotoxicity via mitochondrial ROS and the ferroptosis pathway, which provides novel insights for WGX50 as a promising drug candidate for ...